Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
By A. Baldwin. 2001
1,432 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/0231877cb395971d6317c61f258af1e117f56c91
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Valerie M. Weaver
- F. Giancotti
- Mina J. Bissell
- P. Johnston
- A. Sica
- J. Adams
- Scott W. Lowe
- A. Mantovani
In Molecular Biology
In Oncology
Citations in the corpus
- Erythropoietin Regulates the In Vitro and In Vivo Production of Neuronal Progenitors by Mammalian Forebrain Neural Stem Cells (2001, background): “The results of this study found that EPO actions were mediated by the nuclear translocation of NF- B, a well established regulator of immune and inflammatory responses (Ghosh et al., 1998), and implicated in antiapoptotic and pro-proliferative aspects of oncogenesis (Baldwin, 2001).”
- Modulation of NF-κB Activity by Exchange of Dimers (2003, background): “In turn,ous genes controlling immune response, cell growth, IKK phosphorylates p100, thus directing its polyubiqui-apoptosis, and tissue differentiation (Baldwin, 2001; tination and processing (Senftleben et al., 2001).”
- Role of tumor-associated macrophages in tumor progression and invasion (2006, background): “NF-κB regulates expression of adhesion molecules [24, 25] and cell-surface metalloproteases, such as MMP-9 and MMP-2 [ 26 ].”
- Apoptosis A Link between Cancer Genetics and Chemotherapy (2002, background): “For example, inactivationaction implies that restoring p53 activity in p53 null tu- mors, or activating apoptotic pathways that are directly of NF- B by overexpression of I- B can restore sensitivity of tumor cells to chemotherapy (Baldwin, 2001).”
- beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. (2002, background): “…activation also drives resistance to chemo- and radiation ther- mutant I B , which is resistant to proteolytic degradation, nu- clear translocation of p65 did not occur (data not shown) and allapy (Baldwin, 2001; Baeuerle and Baltimore, 1996) and modifies CANCER CELL : SEPTEMBER 2002 209 Figure 6.”
- Molecular mechanisms of drug resistance (2005, background): “NF-κB has been connected with multiple pathways involved in oncogenesis, including cell cycle regulation and apoptosis [243,244].”
- Apoptosis and Molecular Targeting Therapy in Cancer (2014, background): “Conflict of Interests The authors declare that there is no conflict of interests regarding the publication of this paper.”